> top > docs > PMC:7317273 > spans > 25386-25788 > annotations

PMC:7317273 / 25386-25788 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T159 364-373 Body_part denotes stem cell http://purl.org/sig/ont/fma/fma63368
T160 369-373 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T113 130-150 Disease denotes respiratory diseases http://purl.obolibrary.org/obo/MONDO_0005087
T114 385-392 Disease denotes COVID19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T275 330-331 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T276 364-373 http://purl.obolibrary.org/obo/CL_0000034 denotes stem cell

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
374 393-401 Species denotes patients Tax:9606
377 115-123 Disease denotes infected MESH:D007239
378 130-159 Disease denotes respiratory diseases symptoms MESH:D012818
379 385-392 Disease denotes COVID19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T345 0-402 Sentence denotes Finally, bearing in mind the desires for mitigation of the existing pandemic, the effectiveness of MSCs in virally infected acute respiratory diseases symptoms, and the pieces of evidence from priming strategies for MSCs, we hypothesize that endorsing priming may enhance the effectiveness of MSCs for long-term benefits which is a prerequisite for the success of stem cell therapy in COVID19 patients.

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T436 99-103 DG_47 denotes MSCs
T437 107-114 NCBITaxon:10239 denotes virally
T438 130-141 UBERON:0001004 denotes respiratory
T439 216-220 DG_47 denotes MSCs
T440 293-297 DG_47 denotes MSCs
T441 364-373 CL:0000034 denotes stem cell
T442 385-392 SP_7 denotes COVID19